Zerigo Health, formerly Clarify Medical, is a medical device company focused on developing innovative technology, products and services that improve care for people with chronic skin conditions.
Zerigo Health offers the only comprehensive home solution that seamlessly connects patients and providers to deliver optimal dermatological outcomes.
Zerigo Health was founded in 2014 and is based in San Diego, California.
Zerigo’s precision solution remotely treats and monitors patients with chronic skin conditions using narrowband ultraviolet B (NB-UVB) phototherapy, a proven, standard-of-care treatment.
Zerigo's FDA-cleared, natural light therapy solution safely and effectively shifts dermatological care from the clinic to the controlled convenience of home, keeping physicians and their patients with chronic skin conditions connected with personalized data and insights.
Zerigo's flagship product Zerigo Home Light Therapy System, enables patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress and satisfaction.
Zerigo is backed by 7wire Ventures, General Catalyst, SV Health Investors, H.I.G. Capital, Dragoneer, Cigna Ventures, Leverage Health Solutions, Leaps by Bayer, and others. The company raised $43M in Series B round on Oct 21, 2021. This brings Zerigo's total funding to $67.4M to date.